Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Amello currently holds 350,000 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Amello has been a net seller of AKBA stock. They have purchased $91.2K and sold $657.2K worth of shares.
Jason Amello's most recent insider trade was on Jan 20, 2026, when they sold 350,000 shares at $0.00 per share.
Jason Amello serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 31 insider transactions totaling $748.5K over their tenure at the company.
Jason Amello holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Jason Amello has shown a selling trading pattern, with $91.2K in total purchases and $657.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jason Amello was on Aug 31, 2010, when they sold $466.8K worth of GENZ shares. This transaction involved 6,640 shares at $70.30 per share.
Jason Amello currently owns 350,000 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Amello's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Amello has 31 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Jason Amello and 40,000+ other insiders.